NervGen Pharma Corp. Announces Resignation of Lloyd Mackenzie as Chief Operating Officer, Effective October 2, 2020
September 10, 2020 at 01:35 pm
NervGen Pharma Corp. announced that Lloyd Mackenzie has resigned from his position as Chief Operating Officer effective October 2, 2020, in order to assume the President position of a private company not related to the focus of NervGen. The Company also announced that it has engaged New York based LifeSci Advisors, LLC to provide investor relations services.